Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We conducted a network meta-analysis to evaluate the efficacy and safety of oral antidiabetic drugs (OADs) for gestational diabetes. DATA SOURCES: We searched PubMed, the Cochrane Library, ClinicalTrials.gov, and related reviews from inception to October 2014. STUDY SELECTION: We included randomized clinical trials comparing efficacy and safety between different OADs or OADs vs insulin in patients with gestational diabetes. DATA SYNTHESIS: We included 18 randomized clinical trials. Traditional and network meta-analyses were performed to compare different OADs or OADs vs insulin. Traditional meta-analyses confirmed that there was no significant difference in maternal fasting blood glucose or glycated hemoglobin levels in patients treated with insulin, metformin, and glyburide. Compared to insulin, metformin was associated with lower maternal weight gain (weighted mean difference [WMD], -1.49 kg; 95% confidence interval [CI], -2.26 to -0.31), shorter gestational age (WMD, -0.16 wk; 95% CI, -0.30 to -0.03), and increased incidence of premature birth (odds ratio [OR], 1.63; 95% CI, 1.07 to 2.48). Compared to insulin, glyburide was associated with higher neonatal birth weight (WMD, 130.68 g; 95% CI, 55.98 to 205.38), increased incidence of neonatal hypoglycemia (OR, 2.64; 95% CI, 1.59 to 4.38), and increased incidence of macrosomia (OR, 3.09; 95% CI, 1.59 to 6.04). Network meta-analysis revealed that glyburide was associated with higher maternal weight gain, higher neonatal birth weight, increased incidence of neonatal hypoglycemia, and increased incidence of macrosomia than was metformin. CONCLUSION: Both metformin and glyburide are suitable for use in the management of gestational diabetes because of good glycemic control. However, glyburide treatment is associated with increased risk of neonatal hypoglycemia, high maternal weight gain, high neonatal birth weight, and macrosomia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
Lowe, L. P., Metzger, B. E., Dyer, A. R., Lowe, J., McCance, D. R., Lappin, T. R. J., Trimble, E. R., Coustan, D. R., Hadden, D. R., Hod, M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1687 · Cited by 367
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Placental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Wu, H.-Y., Huang, J.-W., Lin, H.-J., Liao, W.-C., Peng, Y.-S., Hung, K.-Y., Wu, K.-D., Tu, Y.-K., & Chien, K.-L. (2013) · BMJ · doi:10.1136/bmj.f6008 · Cited by 233
Metformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222
Ijäs, H., Vääräsmäki, M., Morin-Papunen, L., Keravuo, R., Ebeling, T., Saarela, T., & Raudaskoski, T. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02763.x · Cited by 215
Cited by
Items 101–131 of 131
Castañeda, A. G., Ruiz, M. C., Garcia, C., Mesa, L. M. V., Toloza, G. A. G., & Betancourt, D. A. (2021) · GLOBAL JOURNAL FOR RESEARCH ANALYSIS · doi:10.36106/gjra/8010274
Gestationsdiabetes und polyzystisches Ovarialsyndrom
Kollmann, M. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00143-y
Brown, Z. A., & Chang, J. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00010-3 · Cited by 2
Pregnancy and the Peripartum Period
Mitta, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-94632-6_8
Vijayam, B., Balaji, T., Balaji, M. S., Seshiah, V., & Ganesan, V. K. (2022) · The Journal of Medical Research · doi:10.31254/jmr.2022.8309
Paneque, A. A. E., Ortiz, M. G. C., Maldonado, E. A. D., Matute, S. G. U., Martínez, C. E. C., & Llumiquinga, P. M. Q. (2022) · doi:10.58594/dzdk6465
Features of Hypoglycemic Pharmacotherapy of Gestational Diabetes Mellitus
Чак, Т. А., Высоцкая, Ю. В., Романова, И. С., & Кожанова, И. Н. (2023) · Рецепт · doi:10.34883/pi.2023.26.6.011
ALTUNAY, F. K. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/5786955648
Special Therapeutic Situations
Drobycki, N., Gupta, O., Choudhary, A., Mirfakhraee, S., Litty, A., Meneghini, L., & Jacob, N. (2020) · American Diabetes Association eBooks · doi:10.2337/9781580406314.ch04
IMPACTOS NA QUALIDADE DE VIDA EM PORTADORAS DE ENDOMETRIOSE
Xavier, J. D. A., Borges, L. L., Cunha, F. A., Neto, M. P. D. C., & da Silva, P. H. C. M. (2023) · Revista fisio&terapia. · doi:10.69849/revistaft/lu10202311301425
Odegard, P. S., Winter, A., & Capoccia, K. L. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch06
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800535
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800514
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800502
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800520
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800505
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800532
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800517
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800529
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800523
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800526
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800538
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800508
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800499
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800496
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800511
Role of nutrients in gestational diabetes management
Wani, S., Pingale, P. L., Amrutkar, S. V., & Kulkarni, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34003-1.00016-x
Bouchghoul, H. (2021) · theses.fr (ABES) · doi:10.70675/148e6519z0c6dz4cbfza432z81cde39ecdbc
Use of miRNAs for prediction of GDM and insulin sensitivity in pregnancy
Légaré, C. (2022) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Wasif, S., & Salgar, V. (2018) · International Journal of Research in Pharmacology & Pharmacotherapeutics · doi:10.61096/ijrpp.v7.iss1.2018.69-79
Metadata
- Authors
- Jiang, Y.-F., Chen, X.-Y., Ding, T., Wang, X.-F., Zhu, Z.-N., & Su, S.-W.
- Affiliations
- Hebei University of Chinese Medicine (CN)
- Hebei Medical University (CN)
- Corresponding author
- Zhu, Zhong-Ning
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-05
- Volume
- 100
- Issue
- 5
- Pages
- 2071-2080
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2129155490
- Cited by
- 124
- References
- 35
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 3 · 2023: 8 · 2022: 9 · 2021: 40 · 2020: 12 · 2019: 7 · 2018: 15 · 2017: 15 · 2016: 3 · 2015: 2
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Hebei Province
- Department of Health of Hebei Province
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- gestational diabetes mellitus, oral antidiabetic drugs, metformin, glibenclamide, insulin therapy, neonatal hypoglycemia, macrosomia, birth weight, gestational weight gain, glycemic control, HbA1c, preterm birth, gestational age, drug safety comparison, drug efficacy comparison, network meta-analysis of randomized controlled trials
- MeSH terms
- Administration, Oral, Blood Glucose, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Randomized Controlled Trials as Topic, Diabetes, Gestational, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.